Inflammatory-associatedmyeloid dendritic cells reveals associations between chronic lung diseases and lung cancer

Abstract

The high risk of patients with chronic lung diseases in developing into lung cancer has been recognised, but the key factors driving such procedure are still barely known. Dendritic cells (DCs) as major antigen presenting cells take part in the immune response in the very upstream, and myeloid DCs regulate the inflammation in pulmonary diseases. In this article, we performed single-cell RNA sequencing (scRNA-seq) analyses on DCs from pulmonary diseases.We explore the DC characteristics in chronic lung diseases, lung cancer and healthy control samples. We discover that a special type of DC, which is highly associated with inflammatory, inf-DC, is abundant in lung cancer samples. Furthermore,we find that there are about 10% patients with chronic lung diseases also has such inf- DC-rich pattern. Such proportion is consistent to the fact that about 10% chronic lung disease patients finally developed into cancer. Our findings indicate inf-DC could be a potential factor to predict the risk of chronic lung disease developing into cancer.

References

[1] HechtSS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002;3(8):461-469.

[2] GodtfredsenNS, LamTH, HanselTT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J. 2008;32(4):844-853.

[3] BaumgartnerKB, SametJM, StidleyCA, Colby TV, WaldronJA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242-248.

[4] WangH, YangL, ZouL, et al. Association between chronic obstructive pulmonary disease and lung cancer: a case–control study in Southern Chinese and a meta-analysis. PLoS One. 2012;7(9):e46144.

[5] GabrielsenME, Romundstad P, LanghammerA, KrokanHE, Skorpen F. Association between a 15q25 gene variant, nicotine-related habits, lung cancer and COPD among 56, 307 individuals from the HUNT study in Norway. Eur J Hum Genet. 2013;21(11):1293-1299.

[6] TzouvelekisA, Karampitsakos T, GomatouG, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece. Pulm Pharmacol Ther. 2020;60:101880.

[7] ZamarronE, PratsE, TejeroE, et al. Static lung hyperinflation is an independent risk factor for lung cancer in patients with chronic obstructive pulmonary disease. Lung Cancer. 2019;128:40-46.

[8] OzawaY, SudaT, NaitoT, et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology. 2009;14(5):723-728.

[9] XuY, MizunoT, SridharanA, et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight. 2016;1(20):e90558.

[10] MaynardA, McCoach CE, RotowJK, et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell. 2020;182(5):1232-1251.e22.

[11] ZilionisR, Engblom C, PfirschkeC, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50(5):1317-1334.e10.

[12] LavinY, Kobayashi S, LeaderA, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell. 2017;169(4):750-765.e17.

[13] Vieira BragaFA, KarG, BergM, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med. 2019;25(7):1153-1163.

[14] ShinJY, WangCY, LinCC, Chu CL. A recently described type 2 conventional dendritic cell (cDC2) subset mediates inflammation. Cell Mol Immunol. 2020;17(12):1215-1217.

[15] BosteelsC, NeytK, VanheerswynghelsM, et al. Inflammatory type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection. Immunity. 2020;52(6):1039-1056.e9.

[16] Jafari NezhadA, Yekta Kooshali MH. Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS One. 2018;13(8):e0202360.

[17] SkillrudDM, OffordKP, MillerRD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105(4):503-507.

[18] KimN, KimHK, LeeK, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.

[19] WangJH, KwasC, WuL. Intercellular adhesion molecule 1 (ICAM-1), but not ICAM-2 and -3, is important for dendritic cell-mediated human immunodeficiency virus type 1 transmission. J Virol. 2009;83(9):4195-4204.

[20] CzopikAK, BynoeMS, PalmN, Raine CS, MedzhitovR. Semaphorin 7A is a negative regulator of T cell responses. Immunity. 2006;24(5):591-600.

[21] de WindeCM, MundayC, ActonSE. Molecular mechanisms of dendritic cell migration in immunity and cancer. Med Microbiol Immunol. 2020;209(4):515-529.

[22] Mouronte-RoibasC, Leiro-Fernández V, Ruano-RaviñaA, et al. Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study. Respir Res. 2019;20(1):198.

[23] AdamsTS, SchuppJC, PoliS, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6(28):eaba1983.

[24] ValenziE, BulikM, TabibT, et al. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis. 2019;78(10):1379-1387.

[25] LambrechtsD, Wauters E, BoeckxB, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277-1289.

[26] MaierB, LeaderAM, ChenST, et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 2020;580(7802):257-262.

[27] BottcherJP, Reis e Sousa C. The role of type 1 conventional dendritic cells in cancer immunity. Trends Cancer. 2018;4(11):784-792.

[28] NagarshethN, WichaMS, ZouW. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559-572.

[29] HaoJ, ZouJ, ZhangJ, et al. scSTAR reveals hidden heterogeneity with a real-virtual cell pair structure across conditions in single-cell RNA sequencing data. Brief Bioinform. 2023;24:bbad062.

[30] DaiS, ZhouX, WangB, et al. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J Mol Med. 2006;84(12):1067-1076.

[31] EfremovaM, Vento-Tormo M, TeichmannSA, Vento-TormoR. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15(4):1484-1506.

[32] MoothaVK, Lindgren CM, ErikssonKF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-273.

[33] HaoL, ChenQ, ChenX, Zhou Q. Integrated analysis of bulk and single-cell RNA-seq reveals the role of MYC signaling in lung adenocarcinoma. Front Genet. 2022;13:1021978.

[34] BelardelliF, Ferrantini M, ProiettiE, KirkwoodJM. Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002;13(2):119-134.

[35] RozeraC, Cappellini GA, D’AgostinoG, et al. Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma. J Transl Med. 2015;13:139.

[36] ReilkoffRA, PengH, MurrayLA, et al. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-beta1-induced pulmonary fibrosis. Am J Respir Crit Care Med. 2013;187(2):180-188.

[37] RimarD, Slobodin G, RosnerI, et al. The role of semaphorin 7a in systemic sclerosis. Harefuah. 2017;156(7):418-421.

[38] BaslanT, HicksJ. Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer. 2017;17(9):557-569.

[39] LimB, LinY, NavinN. Advancing cancer research and medicine with single-cell genomics. Cancer Cell. 2020;37(4):456-470.

[40] WangW, XieM, DouS, CuiL, ZhengC, Xiao W. The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study. Int J Chron Obstruct Pulmon Dis. 2018;13:1167-1175.

[41] MorseC, TabibT, SembratJ, et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur Respir J. 2019;54(2):1802441.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.